Researchers at The University of Texas at Dallas believe that determining the capability of individuals with mild cognitive impairment (MCI) to assess accurately their own cognitive function may help improve diagnosis of that condition — which often precedes an Alzheimer’s disease diagnosis — as well as potentially help better identify those at risk for dementia later.
